Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 8/20 | 0.46 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15452179 | 0.76 | L3MBTL1 (0.52) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| SCHEMBL29426015 | 0.74 | HSP90AA1 (0.65) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| SCHEMBL29425844 | 0.74 | HSP90AA1 (0.48) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| SCHEMBL30854808 | 0.73 | L3MBTL1 (0.56) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| Catalpol SCHEMBL29374095 | 0.72 | HSP90AA1 (0.65) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| SCHEMBL29354606 | 0.72 | HSP90AA1 (0.52) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| SCHEMBL29426036 | 0.71 | L3MBTL1 (0.46) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| SCHEMBL14268483 | 0.71 | L3MBTL1 (0.52) | L3MBTL1POLBCTDSP1HSP90AA1MEN1 | |
| SCHEMBL31345813 | 0.70 | HSP90AA1 (0.70) | L3MBTL1POLBCTDSP1HSP90AA1XDH | |
| Trehalose SCHEMBL23029503 | 0.70 | MEN1 (0.57) | L3MBTL1MEN1KMT2AMAPTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150313928-A1 | NEW APPLICATION OF CATALPOL | SUZHOU YOUSEEN NEW PHARMACY DEVELOPMENT CO., LTD. (CN) | 2015-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150313928-A1 | NEW APPLICATION OF CATALPOL | TPO, PPP2CA, TSHR | L3MBTL1 4402/4885POLB 3741/4885CTDSP1 3863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.